![]() |
|
|
Vol. 15, Issue 4, 1746-1759, April 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Receptor





¶ #
¶ #
* Harvard Medical School, Program in Immunology, Brigham and Women's Hospital, Boston, Massachusetts 02115;
Harvard Medical School, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115;
Harvard Medical School, Department of Gastroenterology Division, Brigham and Women's Hospital, Boston, Massachusetts 02115;
Gastrointestinal Cell Biology and Department of Medicine, Children's Hospital, Boston Massachusetts 02115; and
¶ the Harvard Digestive Diseases Center, Boston, Massachusetts 02115
Submitted November 20, 2003;
Revised January 5, 2004;
Accepted January 18, 2004
Monitoring Editor: Keith Mostov
The human MHC class Irelated neonatal Fc receptor, hFcRn, mediates bidirectional transport of IgG across mucosal barriers. Here, we find that at steady state hFcRn distributes predominantly to an apical intracellular compartment and almost exclusively to the basolateral cell surface of polarized epithelial cells. It moves only transiently to the apical membrane. Ligand binding does not redistribute the steady state location of the receptor. Removal of the cytoplasmic tail that contains di-leucine and tryptophan-based endocytosis motifs or incubation at low temperature (18°C) redistributes the receptor apically. The rates of endocytosis of the full-length hFcRn from the apical or basolateral membrane domains, however, are equal. Thus, the strong cell surface polarity displayed by hFcRn results from dominant basolateral sorting by motifs in the cytoplasmic tail that nonetheless allows for a cycle of bidirectional transcytosis.
2m,
2-microglobulin; h
2m, human
2m; hFcRn, human FcRn; hFcRntl-, tailless hFcRn; IMCD, inner medullary collecting duct; MDCK, Madin-Darby canine kidney; NIP, 5-iodo-4-hydroxy-3-nitro-phenylacetyl; NIP-hIgG1, humanized, NIP-specific human IgG1 monoclonal antibody; pIgR, polymeric immunoglobulin receptor; TfnR, transferrin receptor. Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E03110832. Article and publication date are available at www.molbiolcell.org/cgi/doi/10.1091/mbc.E03110832.
Online version of this article contains supplemental figures. Online version is available at www.molbiolcell.org.
# Corresponding author. Mailing address: Gastroenterology Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115. E-mail address: rblumberg{at}partners.org or Gastrointestinal Cell and Developmental Biology, Gastroenterology and Nutrition Division, Children's Hospital, 300 Longwood Ave, Boston, MA 02115. E-mail address: wayne.lencer{at}tch.harvard.edu.
This article has been cited by other articles:
![]() |
S. Tzaban, R. H. Massol, E. Yen, W. Hamman, S. R. Frank, L. A. Lapierre, S. H. Hansen, J. R. Goldenring, R. S. Blumberg, and W. I. Lencer The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity J. Cell Biol., May 18, 2009; 185(4): 673 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Kuo, E. J. de Muinck, S. M. Claypool, M. Yoshida, T. Nagaishi, V. G. Aveson, W. I. Lencer, and R. S. Blumberg N-Glycan Moieties in Neonatal Fc Receptor Determine Steady-state Membrane Distribution and Directional Transport of IgG J. Biol. Chem., March 27, 2009; 284(13): 8292 - 8300. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Montoyo, C. Vaccaro, M. Hafner, R. J. Ober, W. Mueller, and E. S. Ward Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice PNAS, February 24, 2009; 106(8): 2788 - 2793. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mi, S. Wanjie, S.-T. Lo, Z. Gan, B. Pickl-Herk, R. J. Ober, and E. S. Ward Targeting the Neonatal Fc Receptor for Antigen Delivery Using Engineered Fc Fragments J. Immunol., December 1, 2008; 181(11): 7550 - 7561. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Goebl, C. M. Babbey, A. Datta-Mannan, D. R. Witcher, V. J. Wroblewski, and K. W. Dunn Neonatal Fc Receptor Mediates Internalization of Fc in Transfected Human Endothelial Cells Mol. Biol. Cell, December 1, 2008; 19(12): 5490 - 5505. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Qiao, K. Kobayashi, F.-E. Johansen, L. M. Sollid, J. T. Andersen, E. Milford, D. C. Roopenian, W. I. Lencer, and R. S. Blumberg Dependence of antibody-mediated presentation of antigen on FcRn PNAS, July 8, 2008; 105(27): 9337 - 9342. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Tesar, E. J. Cheung, and P. J. Bjorkman The Chicken Yolk Sac IgY Receptor, a Mammalian Mannose Receptor Family Member, Transcytoses IgY across Polarized Epithelial Cells Mol. Biol. Cell, April 1, 2008; 19(4): 1587 - 1593. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Dickinson, S. M. Claypool, J. A. D'Angelo, M. L. Aiken, N. Venu, E. H. Yen, J. S. Wagner, J. A. Borawski, A. T. Pierce, R. Hershberg, et al. Ca2+-dependent Calmodulin Binding to FcRn Affects Immunoglobulin G Transport in the Transcytotic Pathway Mol. Biol. Cell, January 1, 2008; 19(1): 414 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Braathen, V. S. Hohman, P. Brandtzaeg, and F.-E. Johansen Secretory Antibody Formation: Conserved Binding Interactions between J Chain and Polymeric Ig Receptor from Humans and Amphibians J. Immunol., February 1, 2007; 178(3): 1589 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Datta-Mannan, D. R. Witcher, Y. Tang, J. Watkins, W. Jiang, and V. J. Wroblewski Humanized IgG1 Variants with Differential Binding Properties to the Neonatal Fc Receptor: Relationship to Pharmacokinetics in Mice and Primates Drug Metab. Dispos., January 1, 2007; 35(1): 86 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Newton, Z. Wu, and N. E. Simister Characterization of basolateral-targeting signals in the neonatal Fc receptor J. Cell Sci., June 1, 2005; 118(11): 2461 - 2469. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Shanahan Physiological Basis for Novel Drug Therapies Used to Treat the Inflammatory Bowel Diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol, March 1, 2005; 288(3): G417 - G421. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Ober, C. Martinez, X. Lai, J. Zhou, and E. S. Ward Exocytosis of IgG as mediated by the receptor, FcRn: An analysis at the single-molecule level PNAS, July 27, 2004; 101(30): 11076 - 11081. [Abstract] [Full Text] [PDF] |
||||